Chinese genome research and sequencing company BGI-Shenzhen has finalized its $117 million purchase of genome sequencing company Complete Genomics, marking the first acquisition of a U.S. public company by a Chinese acquirer. O'Melveny & Myers advised BGI; Latham & Watkins advised Complete Genomics.
Latham, O'Melveny Help Ink Chinese Buy of U.S. Company
The Asian Lawyer
March 21, 2013